Microsoft is cashing in on the biggest biotech IPO of 2019

"We believe deeply in the potential for this partnership with Adaptive and have made a substantial financial investment in the company," Peter Lee, Microsoft's corporate vice president of AI and research, wrote in awhen the agreement was announced.

"We have also begun a major research and development collaboration that involves Adaptive's scientists working closely with our top researchers to use Adaptive's innovative sequencing technology and Microsoft's large-scale machine learning and cloud computing capabilities to make deep reading of the immune system a reality."Adaptive mentions Microsoft 74 times in its prospectus.

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

First IPO on China’s Nasdaq-Style Tech Board Sparks a Small FrenzyChina’s latest experiment with a Nasdaq-like listing venue for homegrown technology companies got a boost this week, after the first initial public offering of an electrical-equipment maker drew hordes of investors. IFB TOYOGUAJARDO Normal and fine central planning used to be negative words. 😉
Source: WSJ - 🏆 98. / 63 Read more »

Swiss Re's ReAssure valued at up to $4.2 billion in IPOUK life assurance business ReAssure will be valued at up to 3.3 billion pounds (... 'Bank of America will no longer do business with companies that run detention centers'
Source: Reuters - 🏆 2. / 97 Read more »